Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

National Lung Screening Trial Findings by Age: Medicare-Eligible Versus Under-65 Population.

Pinsky PF, Gierada DS, Hocking W, Patz Jr EF, Kramer BS.

Ann Intern Med. 2014 Sep 9. doi: 10.7326/M14-1484. [Epub ahead of print]

PMID:
25199624
[PubMed - as supplied by publisher]
2.

Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.

Black A, Pinsky PF, Grubb RL 3rd, Falk RT, Hsing AW, Chu L, Meyer T, Veenstra TD, Xu X, Yu K, Ziegler RG, Brinton LA, Hoover RN, Cook MB.

Cancer Epidemiol Biomarkers Prev. 2014 Sep 1. pii: cebp.0700.2014. [Epub ahead of print]

PMID:
25178985
[PubMed - as supplied by publisher]
3.

Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling.

McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ.

PLoS One. 2014 Jun 30;9(6):e99978. doi: 10.1371/journal.pone.0099978. eCollection 2014.

PMID:
24979231
[PubMed - in process]
Free PMC Article
4.

Can symptomatic cancer be distinguished from screen detected cancer?

Schoen RE, Pinsky PF.

Gastroenterology. 2014 Aug;147(2):545-6. doi: 10.1053/j.gastro.2014.05.044. Epub 2014 Jun 25. No abstract available.

PMID:
24973674
[PubMed - indexed for MEDLINE]
5.

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammem├Ągi MC, Hazelton WD, Feuer EJ, McMahon PM.

Ann Intern Med. 2014 Mar 4;160(5):311-20. doi: 10.7326/M13-2316.

PMID:
24379002
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK.

J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. Review.

PMID:
24115361
[PubMed - indexed for MEDLINE]
7.

Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial.

Pinsky PF, Parnes HL, Andriole G.

BJU Int. 2014 Feb;113(2):254-9. doi: 10.1111/bju.12368. Epub 2013 Nov 21.

PMID:
24053621
[PubMed - indexed for MEDLINE]
8.

The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.

Pinsky PF, Church TR, Izmirlian G, Kramer BS.

Cancer. 2013 Nov 15;119(22):3976-83. doi: 10.1002/cncr.28326. Epub 2013 Aug 26.

PMID:
24037918
[PubMed - indexed for MEDLINE]
9.

ROC curves for low-dose CT in the National Lung Screening Trial.

Pinsky PF, Gierada DS, Nath H, Kazerooni EA, Amorosa J.

J Med Screen. 2013;20(3):165-8. doi: 10.1177/0969141313500666. Epub 2013 Aug 30.

PMID:
24009092
[PubMed - indexed for MEDLINE]
10.

National lung screening trial: variability in nodule detection rates in chest CT studies.

Pinsky PF, Gierada DS, Nath PH, Kazerooni E, Amorosa J.

Radiology. 2013 Sep;268(3):865-73. doi: 10.1148/radiol.13121530. Epub 2013 Apr 16.

PMID:
23592767
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Factors associated with the risk of adenoma recurrence in distal and proximal colon.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Cross AJ.

Digestion. 2013;87(3):141-6. doi: 10.1159/000346281. Epub 2013 Mar 15.

PMID:
23548665
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.

Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD.

Int J Cancer. 2013 May 1;132(9):2127-33. doi: 10.1002/ijc.27909. Epub 2012 Nov 5.

PMID:
23065684
[PubMed - indexed for MEDLINE]
13.

Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?

Pinsky PF, Berg CD.

J Med Screen. 2012 Sep;19(3):154-6. doi: 10.1258/jms.2012.012010. Epub 2012 Oct 11.

PMID:
23060474
[PubMed - indexed for MEDLINE]
14.

Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Pinsky PF, Black A, Parnes HL, Grubb R, David Crawford E, Miller A, Reding D, Andriole G.

Cancer Epidemiol. 2012 Dec;36(6):e401-6. doi: 10.1016/j.canep.2012.08.008. Epub 2012 Sep 19.

PMID:
23000116
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer.

Rogal SS, Pinsky PF, Schoen RE.

Clin Gastroenterol Hepatol. 2013 Jan;11(1):73-8. doi: 10.1016/j.cgh.2012.08.002. Epub 2012 Aug 16.

PMID:
22902761
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials.

Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H.

Cancer. 2013 Feb 1;119(3):593-601. doi: 10.1002/cncr.27774. Epub 2012 Aug 14.

PMID:
22893105
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.

PMID:
22612596
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC.

Gastrointest Endosc. 2012 Mar;75(3):612-20. doi: 10.1016/j.gie.2011.10.024.

PMID:
22341106
[PubMed - indexed for MEDLINE]
19.

Comparative effectiveness of digital versus film-screen mammography.

Pinsky PF.

Ann Intern Med. 2012 Feb 7;156(3):250; author reply 251. doi: 10.7326/0003-4819-156-3-201202070-00023. No abstract available.

PMID:
22312151
[PubMed - indexed for MEDLINE]
20.

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team.

J Natl Cancer Inst. 2012 Feb 22;104(4):280-9. doi: 10.1093/jnci/djr549. Epub 2012 Jan 31.

PMID:
22298838
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk